Accelerating the Development of Solid Tumour Therapies through QSP
Explore a 15-minute conference talk on accelerating solid tumour therapy development through Quantitative Systems Pharmacology (QSP). Delivered by Cameron Meaney from Simulations Plus Inc, this presentation is part of the Frontiers in Computational and M…
Multivalent RNA CAR-T Cell for Malignant Glioma
Explore innovative RNA CAR-T cell therapy for glioblastoma, addressing tumor heterogeneity through a multivalent approach. Learn about the development, testing, and potential of this promising treatment strategy.
Optimizing CAR Structures to Enhance Efficacy in Solid Tumors - Moving from Linear to Lateral Architectures
Explore advanced CAR T-cell therapy strategies for solid tumors, focusing on lateral architectures to overcome efficacy challenges in non-hematological cancers.
Cytokine Armored CAR NK Cell Therapy for Advanced Ovarian Cancer
Explore innovative CAR NK cell therapy for ovarian cancer using non-viral transposon engineering and CRISPR/Cas9 editing. Learn about advancements in immunotherapy and potential applications in solid tumors.
MRD in Solid Tumor and Hematological Indications: Today and Tomorrow
Explore measurable residual disease (MRD) in solid tumors and hematological indications, its clinical applications, and future developments in cancer treatment and monitoring.
Discovery of a Novel C0702 Restricted Epitope on MAGE A1 and Preclinical Development of an Enhanced TCR-T Cell Therapy
Explore novel C0702 restricted epitope on MAGE A1 and its preclinical development for enhanced anti-tumor T-cell responses in cancer immunotherapy.
Memory-Rich CAR T Cell Engineering by PiggyBac Transposon System for Solid Malignancies
Explore novel CAR-T cell engineering using piggyBac transposon for solid tumors. Learn about memory-rich T cells, manufacturing processes, and potential clinical applications in cancer immunotherapy.
Modelling Hypoxia-Driven Cell Reprogramming in Solid Tumours
Explore mathematical models of hypoxia's impact on cell reprogramming in solid tumors, uncovering key mechanisms and potential therapeutic targets.
Cancer's Faustian Bargain: Exploiting Whole Genome Doubling in Solid Tumors
Explore whole genome doubling in solid tumors and its implications for cancer treatment. Gain insights from oncology experts on this crucial aspect of cancer biology.
Overcoming Challenges of Somatic RNA Variant Calling in Solid Tumors
Explore techniques for accurate somatic RNA variant calling in solid tumors, addressing key challenges and improving cancer genomics analysis.
Comparative Analysis of RNA Expression Identifies Druggable Targets in Pediatric Solid Tumors
Explore RNA expression analysis for identifying targetable therapies in challenging pediatric solid tumors, advancing precision medicine for young cancer patients.
The Evolution of Precision Diagnostics in Advancing Treatment Strategies of Solid Tumors
Explore advancements in multi-omic approaches for comprehensive tumor analysis, accelerating precision medicine development while addressing challenges in diagnostic laboratory integration.
Reprogramming Natural Killer Cells for Cancer Immunotherapy
Explore genetic engineering approaches to enhance natural killer cells for cancer immunotherapy, focusing on overcoming challenges in targeting aggressive solid tumors and improving immune responses.
Scalable Genetic Discovery Systems for Human T Cell Therapies
Explore non-viral genome targeting and pooled knockin screening for advancing cellular therapies in solid tumors. Learn about innovative methods for large-scale genetic engineering of human immune cells.
Unraveling the Roles of Copy Number Variants in Tumorigenesis
Explore genomic analysis of cancer cells, focusing on Copy Number Variants (CNVs) as biomarkers and their detection through OncoScan CNV assays for understanding tumor development and progression.